Matej Mikulic
United States and global research expert with over 10 years of experience covering health-related topics at Statista. His primary focus is on pharma-biotech and the digitization of health. During the coronavirus pandemic, he was responsible for the global coverage of the pandemic at Statista.com.
![Matej Mikulic](https://cdn.statically.io/img/cdn.statcdn.com/static/../CMS/contactperson/ERI285_1713877581.png)
Latest statistics
![Leading global contract research organizations (CROs) based on 2023 revenue (in million U.S. dollars)](https://cdn.statcdn.com/Statistic/730000/732804-blank-100.png)
Leading global contract research organizations (CROs) based on 2023 revenue (in million U.S. dollars)
![Global pharmacy benefit management (PBM) market forecast for 2024 and 2029 (in billion U.S. dollars)](https://cdn.statcdn.com/Statistic/1385000/1387058-blank-100.png)
Global pharmacy benefit management (PBM) market forecast for 2024 and 2029 (in billion U.S. dollars)
![Size of the migraine drugs market worldwide in 2023 and a forecast for 2032 (in billion U.S. dollars)](https://cdn.statcdn.com/Statistic/1255000/1258168-blank-100.png)
Size of the migraine drugs market worldwide in 2023 and a forecast for 2032 (in billion U.S. dollars)
![Size of the immunoglobulin market worldwide in 2023 and a forecast for 2029 (in billion U.S. dollars)](https://cdn.statcdn.com/Statistic/1255000/1258090-blank-100.png)
Size of the immunoglobulin market worldwide in 2023 and a forecast for 2029 (in billion U.S. dollars)
![Average time between marketing authorization and patient access for combination therapies in Europe as of 2024, by country (in days)](https://cdn.statcdn.com/Statistic/1245000/1248725-blank-100.png)
Average time between marketing authorization and patient access for combination therapies in Europe as of 2024, by country (in days)